Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for Postherpetic Neuralgia
NCT04664530Phase 4Unknown
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Nov 2020
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of esketamine in postherpetic neuralgia (PHN), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Status: unknown.
02
Drugs
esketamine
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT04664530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04664530.